Predictors at Diagnosis for Start of Biologic Disease Modifying Anti-Rheumatic Drugs in Patients with Early Rheumatoid Arthritis

被引：0
|
作者：
Hameed, M. [1 ]
Exarchou, S. [1 ]
Eberhard, A. [1 ]
Sharma, A. [1 ]
Bergstrom, U. [1 ]
Einarsson, J. [2 ]
Turesson, C. [1 ]
机构：
[1] Lund Univ, Rheumatol, Dept Clin Sci, Malmo, Sweden
[2] Lund Univ, Rheumatol, Dept Clin Sci, Malmo, Sweden
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2023年 / 52卷
关键词：
Rheumatoid arthritis; bDMARDs; Predictors;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP08
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [1] Predictors at Diagnosis for Start of Biologic Disease Modifying Anti-Rheumatic Drugs in Patients with Early Rheumatoid Arthritis
    Hameed, Mohaned
    Exarchou, Sofia
    Eberhard, Anna
    Sharma, Ankita
    Bergstrom, Ulf
    Einarsson, Jon
    Turesson, Carl
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2831 - 2833
  • [2] SARCOPENIA IN PATIENTS WITH RHEUMATOID ARTHRITIS ON THE TREATMENT WITH BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Hasegawa, E.
    Ito, S.
    Kurosawa, Y.
    Taniguchi, S.
    Kobayashi, D.
    Abe, A.
    Otani, H.
    Nakazono, K.
    Murasawa, A.
    Narita, I.
    Ishikawa, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 985 - 985
  • [3] ADHERENCE TO BIOLOGIC AND CONVENTIONAL DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Mishra, P.
    VALUE IN HEALTH, 2018, 21 : S198 - S198
  • [4] Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Choy, Ernest
    Aletaha, Daniel
    Behrens, Frank
    Finckh, Axel
    Gomez-Reino, Juan
    Gottenberg, Jacques-Eric
    Schuch, Florian
    Rubbert-Roth, Andrea
    RHEUMATOLOGY, 2017, 56 (05) : 689 - 697
  • [5] Utilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer
    Xerxes Pundole
    Natalia V. Zamora
    Harish Siddhanamatha
    Heather Lin
    Jean Tayar
    Leung Cheuk Hong
    Liang Li
    Maria E. Suarez-Almazor
    Clinical Rheumatology, 2020, 39 : 787 - 794
  • [6] Utilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer
    Pundole, Xerxes
    Zamora, Natalia V.
    Siddhanamatha, Harish
    Lin, Heather
    Tayar, Jean
    Hong, Leung Cheuk
    Li, Liang
    Suarez-Almazor, Maria E.
    CLINICAL RHEUMATOLOGY, 2020, 39 (03) : 787 - 794
  • [7] SECONDARY SARCOPENIA IN RHEUMATOID ARTHRITIS PATIENTS TREATED BY BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Hasegawa, Eriko
    Ito, Satoshi
    Kurosawa, Yoichi
    Kobayashi, Daisuke
    Abe, Asami
    Otani, Hiroshi
    Nakazono, Kiyoshi
    Murasawa, Akira
    Narita, Ichiei
    Ishikawa, Hajime
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1622 - 1622
  • [8] THE MODERATING EFFECTS OF DEPRESSION ON BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS
    Rathbun, A. M.
    Harrold, L. R.
    Reed, G. W.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 631 - 631
  • [9] Effectiveness of sequential biologic and targeted disease modifying anti-rheumatic drugs for rheumatoid arthritis
    Zhao, Sizheng Steven
    Kearlsey-Fleet, Lianne
    Bosworth, Ailsa
    Watson, Kath
    Hyrich, Kimme L.
    RHEUMATOLOGY, 2022, 61 (12) : 4678 - 4686
  • [10] PREDICTORS OF BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUG INITIATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS IN KOREA
    Park, E. H.
    Shin, A.
    Ha, Y. J.
    Lee, Y. J.
    Lee, E. B.
    Song, Y. W.
    Kang, E. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 302 - 302
12345